Literature DB >> 9757994

The detection of diminished ovarian reserve in infertile women.

F I Sharara1, R T Scott, D B Seifer.   

Abstract

Women in their mid to late 30s and early 40s with infertility constitute the largest portion of the total infertility population. These women frequently undergo multiple testing, and most will require expensive and invasive therapies, including assisted reproductive technologies, with markedly reduced pregnancy rates in those older than 40. These women also have a higher incidence of pregnancy loss even after documentation of fetal cardiac activity by ultrasonography. Identifying those women who have a very low chance of pregnancy (and a high chance of pregnancy loss) with their own gametes presents a daily challenge to the practicing clinician, especially before embarking on expensive treatments. This article reviews the contemporary investigation of reproductive aging with basal and provocative tests. Women with markedly diminished ovarian reserve should be counseled on their low chances of conception with their own gametes, even with assisted reproductive technologies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9757994     DOI: 10.1016/s0002-9378(98)70087-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  29 in total

1.  Mean ovarian diameter (MOD) as a predictor of poor ovarian response.

Authors:  Iavor K Vladimirov; Desislava M Tacheva; Krassimir B Kalinov
Journal:  J Assist Reprod Genet       Date:  2004-03       Impact factor: 3.412

2.  AMH in women with diminished ovarian reserve: potential differences by FMR1 CGG repeat level.

Authors:  Lisa M Pastore; Timothy L McMurry; Christopher D Williams; Valerie L Baker; Steven L Young
Journal:  J Assist Reprod Genet       Date:  2014-06-18       Impact factor: 3.412

3.  IVF performance of women who have fluctuating early follicular FSH levels.

Authors:  A Lass; A Gerrard; N Abusheikha; F Akagbosu; P Brinsden
Journal:  J Assist Reprod Genet       Date:  2000-11       Impact factor: 3.412

4.  Donor oocyte cytoplasmic transfer did not enhance implantation of embryos of women with poor ovarian reserve.

Authors:  M S Opsahl; L P Thorsell; M E Geltinger; M A Iwaszko; K L Blauer; R J Sherins
Journal:  J Assist Reprod Genet       Date:  2002-03       Impact factor: 3.412

5.  Attitudes towards potentially carrying the FMR1 premutation: before vs after testing of non-carrier females with diminished ovarian reserve.

Authors:  Lisa M Pastore; Maria Antero; Karen Ventura; J Kim Penberthy; Semara A Thomas; Logan B Karns
Journal:  J Genet Couns       Date:  2014-05-03       Impact factor: 2.537

6.  The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination.

Authors:  Ernest Hung Yu Ng; William Shu Biu Yeung; Pak Chung Ho
Journal:  J Assist Reprod Genet       Date:  2005-10       Impact factor: 3.412

7.  Levels and associations among self-esteem, fertility distress, coping, and reaction to potentially being a genetic carrier in women with diminished ovarian reserve.

Authors:  Ceylan Cizmeli; Marci Lobel; Jason Franasiak; Lisa M Pastore
Journal:  Fertil Steril       Date:  2013-03-15       Impact factor: 7.329

8.  Supply of and demand for assisted reproductive technologies in the United States: clinic- and population-based data, 1995-2010.

Authors:  Elizabeth Hervey Stephen; Anjani Chandra; Rosalind Berkowitz King
Journal:  Fertil Steril       Date:  2015-10-24       Impact factor: 7.329

9.  The significance of antral follicle size prior to stimulation in predicting ovarian response in a multiple dose GnRH antagonist protocol.

Authors:  Qiaohong Lai; Cai Chen; Zhijun Zhang; Shu Zhang; Qilin Yu; Ping Yang; Jun Hu; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

10.  Prognostic implication of apoptosis in human luteinized granulosa cells during IVF-ET.

Authors:  Chang Suk Suh; Byung Chul Jee; Young Min Choi; Jung Gu Kim; Jin Yong Lee; Shin Yong Moon; Seok Hyun Kim
Journal:  J Assist Reprod Genet       Date:  2002-05       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.